# Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma

> **NCT06146127** · — · UNKNOWN · sponsor: **Inserm U955** · enrollment: 300 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **OTHER:** phenotyping

## Key facts

- **NCT ID:** NCT06146127
- **Lead sponsor:** Inserm U955
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-01-15
- **Primary completion:** 2023-01-15
- **Final completion:** 2025-01-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06146127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06146127, "Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06146127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*